Gabapentin-induced mitogenic activity in rat pancreatic acinar cells

Toxicological Sciences

Volumn 55, Issue 1, 2000, Pages 52-59

  Dethloff, Lloyd ^b   Barr, Bridget ^b   Bestervelt, Lorelle ^a,b   Bulera, Steven ^b   Sigler, Robert ^b   LaGattuta, Mark ^b   De La Iglesia, Felix ^b  

^a NSF INTERNATIONAL   (United States)

^b PFIZER INC   (United States)

Author keywords

Acinar cell tumors; Calcium mobilization; Cholecystokinin (CCK)

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM CHANNEL; CHOLECYSTOKININ OCTAPEPTIDE; GABAPENTIN;

ACINAR CELL; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CALCIUM MOBILIZATION; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; IMMEDIATE EARLY GENE; MALE; NONHUMAN; ONCOGENE; PANCREAS TUMOR; RAT;

EID: 0034065171     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/55.1.52     Document Type: Article

References (26)

1. Bell, R. H., Jr, Kuhlman, E. T., Jensen, R. T., and Longnecker, D. S. (1992). Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas. Cancer Res. 52, 3295-3299.
2. Bockman, D. E. (1981). Cells of origin of pancreatic cancer: Experimental animal tumors related to human pancreas. Cancer 47, 1528-1534.
3. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. Christophe, J. (1994). Pancreatic tumoral cell line AR42J: An amphicrine model. Am. J. Physiol. 266, G963-G971.
5. de la Iglesia, F. A., Tierney, B. M., and Dethloff, L. A. (1997). Cholecystokinin does not modulate gabapentin-induced pancreatic acinar cell tumors in rats. The Toxicologist 36, 905a.
6. Douglas, B. R., Woutersen, R. A., Jansen, J. B., deJong, A. J., Rovati, L. C., and Lamers, C. B. (1989). Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas. Gastroenterology 96, 462-469.
7. Duan, R. D., and Williams, J. A. (1994). Cholecystokinin rapidly activates mitogen-activated protein kinase in rat pancreatic acini. Am. J. Physiol. 267, G401-G408.
8. 2δ subunit of a calcium channel. J. Biol. Chem. 271, 5768-5776.
9. Goke, B., Printz, H., Koop, I., Rausch, U., Richter, G., Arnold, R., and Adler, G. (1986). Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (camostate). Pancreas 1, 509-515.
10. Gumbmann, M. R., Dugan, G. M., Spangler, W. L., Baker, E. C., and Rackis, J. J. (1989). Pancreatic response in rats and mice to trypsin inhibitors from soy and potato after short- and long-term dietary exposure. J. Nutr. 119, 1598-1609.
11. Herrington, M. K., Permert, J., Kazakoff, K. R., Zucker, K. A., Bilchik, A. J., Pour, P. M., and Adrian, T. E. (1994). Effects of raw soya diet and cholecystokinin in receptor blockade on pancreatic growth and tumor initiation in the hamster. Cancer Lett. 82, 7-16.
12. Howatson, A. G., and Carter, D. C. (1985). Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model. Br. J. Cancer 51, 107-114.
13. Louie, D. S. (1994). Cholecystokinin-stimulated intracellular signal transduction pathways. J. Nutr. 124(Suppl. 8), 1315S-1320S.
14. Lu, L., and Logsdon, C. D. (1992). CCK, bombesin, and carbachol stimulate c-fos, c-jun, and c-myc oncogene expression in rat pancreatic acini. Am. J. Physiol. 263, G327-G332.
15. Maruchi, N., Brian, D., Ludwig, J., Elveback L. R., and Kurland L. T. (1979). Cancer of the pancreas in Olmsted County, Minnesota, 1935-1974. Mayo Clin. Proc. 54, 245-249.
16. McGuinness, E. E., Morgan, R. G., Levison, D. A., Frape, D. L., Hopwood, D., and Wormsley, K. G. (1980). The effects of long-term feeding of soya flour on the rat pancreas. Scand. J. Gastroenterol. 15, 497-502.
17. Obourn, J. D., Frame, S. R., Chiu, T., Solomon, T. E., and Cook, J. C. (1997). Evidence that A8947 enhances pancreas growth via a trypsin inhibitor mechanism. Toxicol. Appl. Pharmacol. 146, 116-126.
18. Povoski, S. P., Zhou, W., Longnecker, D. S., Roebuck, B. D., and Bell, R. H., Jr. (1993). Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Cancer Res. 53, 3925-3929.
19. Rao, M. S. (1987). Animal models of exocrine pancreatic carcinogenesis. Cancer Metastasis Rev. 6, 665-676.
20. Rehfeld, J. F. (1998). How to measure cholecystokinin in tissue, plasma, and cerebrospinal fluid. Regul. Pept. 78, 31-39.
21. Sigler, R. E., Gough, A. W., and de la Iglesia, F. A. (1995). Pancreatic acinar cell neoplasia in male Wistar rats following 2 years of gabapentin exposure. Toxicology 98, 73-82.
22. Silverman, J. A., Kuhlman, E. T., Zurlo, J., Yager, J. D., and Longnecker, D. S. (1990). Expression of c-myc, c-raf-l, and c-Ki-ras in azaserine-induced pancreatic carcinomas and growing pancreas in rats. Mol. Carcinog. 3, 379-386.
23. 3H]gabapentin binding to a novel site in rat brain: homogenate binding studies. Eur. J. Pharmacol. 244, 293-301.
24. 2 pathways to mediate pancreatic amylase secretion. Am. J. Physiol. 269, G435-G444.
25. Vollmer, K.-O., von Hodenberg, A., and Koll, E. U. (1986). Pharmacokinetics and metabolism of gabapentin in rat, dog, and man. Arzneim-Forsch/Drug Res 36, 820-839.
26. Zhou, W., Povoski, S. P., Longnecker, D. S., and Bell, R. H., Jr. (1992). Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: Receptor determination and characterization. Cancer Res. 52, 6905-6911.